Durability of endovascular therapy for symptomatic intracranial atherosclerosis

Stroke

Volumn 39, Issue 6, 2008, Pages 1766-1769

  Mazighi, Mikael ^a   Yadav, Jay S ^b   Abou Chebl, Alex ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CardioMEMS Inc   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Atherosclerosis; Intracranial stenosis; Stroke management

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BALLOON CATHETER; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; STENT; TREATMENT FAILURE; TREATMENT OUTCOME; BRAIN ARTERY; FOLLOW UP; GRAFT OCCLUSION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECURRENT DISEASE; STATISTICS; STROKE; TIME; TRANSIENT ISCHEMIC ATTACK;

AGED; ANGIOPLASTY, BALLOON; BRAIN ISCHEMIA; CEREBRAL ARTERIES; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STENTS; STROKE; TIME; TREATMENT OUTCOME;

EID: 46249128389     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.500587     Document Type: Article

References (16)

1. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577- 617.
2. Stenting of symptomatic atherosclerotic lesions in the vertebral or intra-cranial arteries (SSYLVIA): study results. Stroke. 2004;35:1388 -1392.
3. Zaidat O, Klucznik R, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Alexander M, Lane B, Lynn M, Chimowitz M. An NIH funded multi-center registry on the use of the Wingspan intracranial stent (WIS) for high risk patients with symptomatic intracranial arterial stenosis (SIAS). International Stroke Conference, San Francisco: Feb 9, 2007.
4. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37:1016-1020.
5. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, Kim TS, Kim JK, Kang HK. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology. 2005;237: 620-626.
6. Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology. 2005;64:1055-1057.
7. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004;35:1375-1380.
8. Connors JJ III, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91:415-423.
9. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
10. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006; 113:555-563.
11. Gupta R, Schumacher HC, Mangla S, Meyers PM, Duong H, Khandji AG, Marshall RS, Mohr JP, Pile-Spellman J. Urgent endovascular re-vascularization for symptomatic intracranial atherosclerotic stenosis. Neurology. 2003;61:1729-1735.
12. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angio-graphic follow-up. Stroke. 2005;36:e165-e168.
13. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37:2562-2566.
14. Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, Janjua N, Alkawi A. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044-1051; discussion 1051.
15. Rodriguez AE, Mieres J, Fernandez-Pereira C, Vigo CF, Rodriguez-Alemparte M, Berrocal D, Grinfeld L, Palacios I. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol. 2006;47:205-207.
16. Rasmussen PA, Perl J II, Barr JD, Markarian GZ, Katzan I, Sila C, Krieger D, Furlan AJ, Masaryk TJ. Stent-assisted angioplasty of intra-cranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg. 2000;92:771-778.